
Daniel M. Sullivan
Director (ID: 12309, Phone: (571)272-0900 , Office: P/1600 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1600, 1611, 1621, 1636 |
| Total Applications | 646 |
| Issued Applications | 156 |
| Pending Applications | 192 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6225717
[patent_doc_number] => 20020004583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Gene that imparts selective proliferation activity'
[patent_app_type] => new
[patent_app_number] => 09/905592
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4007
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004583.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905592
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905592 | Gene that imparts selective proliferation activity | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6660381
[patent_doc_number] => 20030135025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/904992
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 121160
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20030135025.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904992
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904992 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 11, 2001 | Abandoned |
Array
(
[id] => 997323
[patent_doc_number] => 06914574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Multiband planar antenna'
[patent_app_type] => utility
[patent_app_number] => 10/332431
[patent_app_country] => US
[patent_app_date] => 2001-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 2983
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/914/06914574.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332431 | Multiband planar antenna | Jul 10, 2001 | Issued |
Array
(
[id] => 5877239
[patent_doc_number] => 20020049989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Transgenic mice containing stefin homolog protease inhibitor gene disruptions'
[patent_app_type] => new
[patent_app_number] => 09/904180
[patent_app_country] => US
[patent_app_date] => 2001-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19847
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049989.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904180
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904180 | Transgenic mice containing stefin homolog protease inhibitor gene disruptions | Jul 10, 2001 | Issued |
| 09/856251 | Method for preparing suspension of stable posiplexes | Jul 10, 2001 | Abandoned |
Array
(
[id] => 6792506
[patent_doc_number] => 20030087850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Gene therapy for dry eye syndrome'
[patent_app_type] => new
[patent_app_number] => 09/902939
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12290
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087850.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902939
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902939 | Gene therapy for dry eye syndrome | Jul 9, 2001 | Abandoned |
| 09/903370 | Hypertension associated transcription factors and uses therefor | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6560802
[patent_doc_number] => 20020164715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Chromosome 3p21.3 genes are tumor suppressors'
[patent_app_type] => new
[patent_app_number] => 09/902003
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 48865
[patent_no_of_claims] => 116
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164715.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902003 | Chromosome 3p21.3 genes are tumor suppressors | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6696789
[patent_doc_number] => 20030108983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/902572
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 117970
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108983.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902572
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902572 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6535790
[patent_doc_number] => 20020026654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Transgenic mice containing tryptase gene disruptions'
[patent_app_type] => new
[patent_app_number] => 09/900754
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19834
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20020026654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900754
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900754 | Transgenic mice containing tryptase gene disruptions | Jul 5, 2001 | Abandoned |
Array
(
[id] => 6370574
[patent_doc_number] => 20020059654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'pCAR and its uses'
[patent_app_type] => new
[patent_app_number] => 09/899634
[patent_app_country] => US
[patent_app_date] => 2001-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3731
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20020059654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899634
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899634 | pCAR and its uses | Jul 4, 2001 | Issued |
Array
(
[id] => 1323437
[patent_doc_number] => 06602680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-05
[patent_title] => 'Production of gabaergic cells'
[patent_app_type] => B2
[patent_app_number] => 09/900527
[patent_app_country] => US
[patent_app_date] => 2001-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 65
[patent_no_of_words] => 12899
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602680.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900527 | Production of gabaergic cells | Jul 4, 2001 | Issued |
Array
(
[id] => 6752210
[patent_doc_number] => 20030046731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Promoters for gene expression in caryopses of plants'
[patent_app_type] => new
[patent_app_number] => 09/899718
[patent_app_country] => US
[patent_app_date] => 2001-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11942
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20030046731.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899718
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899718 | Promoters for gene expression in caryopses of plants | Jul 4, 2001 | Issued |
Array
(
[id] => 1160396
[patent_doc_number] => 06759039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Culturing pancreatic stem cells having a specified, intermediate stage of development'
[patent_app_type] => B2
[patent_app_number] => 09/895585
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 15958
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09895585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/895585 | Culturing pancreatic stem cells having a specified, intermediate stage of development | Jun 28, 2001 | Issued |
Array
(
[id] => 6414469
[patent_doc_number] => 20020038468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Transgenic mice containing chordin gene disruptions'
[patent_app_type] => new
[patent_app_number] => 09/897699
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20174
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20020038468.pdf
[firstpage_image] =>[orig_patent_app_number] => 09897699
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/897699 | Transgenic mice containing chordin gene disruptions | Jun 28, 2001 | Abandoned |
Array
(
[id] => 690287
[patent_doc_number] => 07074590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Chimeric promoters'
[patent_app_type] => utility
[patent_app_number] => 09/886942
[patent_app_country] => US
[patent_app_date] => 2001-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27901
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886942
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886942 | Chimeric promoters | Jun 20, 2001 | Issued |
Array
(
[id] => 1340154
[patent_doc_number] => 06586185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-01
[patent_title] => 'Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances'
[patent_app_type] => B2
[patent_app_number] => 09/886319
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33460
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586185.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886319 | Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances | Jun 19, 2001 | Issued |
Array
(
[id] => 1240006
[patent_doc_number] => 06686339
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia'
[patent_app_type] => B1
[patent_app_number] => 09/763063
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15318
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686339.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763063
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763063 | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia | Jun 14, 2001 | Issued |
Array
(
[id] => 5888401
[patent_doc_number] => 20020012905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Toxicity typing using liver stem cells'
[patent_app_type] => new
[patent_app_number] => 09/881526
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19700
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20020012905.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881526
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881526 | Toxicity typing using liver stem cells | Jun 13, 2001 | Abandoned |
Array
(
[id] => 6242095
[patent_doc_number] => 20020045179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Toxicity typing using mesenchymal stem cells'
[patent_app_type] => new
[patent_app_number] => 09/881475
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17103
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045179.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881475
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881475 | Toxicity typing using mesenchymal stem cells | Jun 13, 2001 | Abandoned |